Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Knuf

Showing results (61-70 of 113) with videos related to

Pageof 12
Sort By:
Cornea|April 25, 2017
Axial Length and Anterior Segment Alterations in Former Preterm Infants and Full-Term Neonates Analyzed With Scheimpflug ImagingAchim Fieß, Ruth Kölb-Keerl, Markus Knuf, et al.
The Pediatric Infectious Disease Journal|March 28, 2009
Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccinesBertrand Chevallier, Timo Vesikari, Jerzy Brzostek, et al.
GMS Hygiene and Infection Control|June 18, 2020
Children and adolescents in the CoVid-19 pandemic: Schools and daycare centers are to be opened again without restrictions. The protection of teachers, educators, carers and parents and the general hygiene rules do not conflict with thisPeter Walger, Ulrich Heininger, Markus Knuf, et al.
The Pediatric Infectious Disease Journal|March 28, 2009
Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccinesJacek Wysocki, Juan C Tejedor, Dutlef Grunert, et al.
The Pediatric Infectious Disease Journal|October 11, 2011
Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in childrenSteven Black, Uwe Nicolay, Timo Vesikari, et al.
Vaccine|January 17, 2018
Immunization of preterm infants with GSK's hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: A review of safety and immunogenicityFelix Omeñaca, Liliana Vázquez, Pilar Garcia-Corbeira, et al.
The Journal of Pediatrics|March 23, 2010
Booster vaccination after neonatal priming with acellular pertussis vaccineMarkus Knuf, Heinz-Josef Schmitt, Jeanne-Marie Jacquet, et al.
Human Vaccines & Immunotherapeutics|January 27, 2015
Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for childrenMarkus Knuf, Geert Leroux-Roels, Hans Rümke, et al.
Human Vaccines & Immunotherapeutics|April 19, 2023
Penta- and hexavalent vaccination of extremely and very-to-moderate preterm infants born at less than 34 weeks and/or under 1500 g: A systematic literature reviewMarkus Knuf, Marie-Laure Charkaluk, Phung Nguyen The Nguyen, et al.
Clinical Therapeutics|April 22, 2014
Pneumococcal vaccination in Europe: schedule adherenceAlain Gervaix, Filippo Ansaldi, António Brito-Avô, et al.
Pageof 12

Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
Cornea|April 25, 2017
Axial Length and Anterior Segment Alterations in Former Preterm Infants and Full-Term Neonates Analyzed With Scheimpflug ImagingAchim Fieß, Ruth Kölb-Keerl, Markus Knuf, et al.
The Pediatric Infectious Disease Journal|March 28, 2009
Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccinesBertrand Chevallier, Timo Vesikari, Jerzy Brzostek, et al.
GMS Hygiene and Infection Control|June 18, 2020
Children and adolescents in the CoVid-19 pandemic: Schools and daycare centers are to be opened again without restrictions. The protection of teachers, educators, carers and parents and the general hygiene rules do not conflict with thisPeter Walger, Ulrich Heininger, Markus Knuf, et al.
The Pediatric Infectious Disease Journal|March 28, 2009
Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccinesJacek Wysocki, Juan C Tejedor, Dutlef Grunert, et al.
The Pediatric Infectious Disease Journal|October 11, 2011
Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in childrenSteven Black, Uwe Nicolay, Timo Vesikari, et al.
Vaccine|January 17, 2018
Immunization of preterm infants with GSK's hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: A review of safety and immunogenicityFelix Omeñaca, Liliana Vázquez, Pilar Garcia-Corbeira, et al.
The Journal of Pediatrics|March 23, 2010
Booster vaccination after neonatal priming with acellular pertussis vaccineMarkus Knuf, Heinz-Josef Schmitt, Jeanne-Marie Jacquet, et al.
Human Vaccines & Immunotherapeutics|January 27, 2015
Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for childrenMarkus Knuf, Geert Leroux-Roels, Hans Rümke, et al.
Human Vaccines & Immunotherapeutics|April 19, 2023
Penta- and hexavalent vaccination of extremely and very-to-moderate preterm infants born at less than 34 weeks and/or under 1500 g: A systematic literature reviewMarkus Knuf, Marie-Laure Charkaluk, Phung Nguyen The Nguyen, et al.
Clinical Therapeutics|April 22, 2014
Pneumococcal vaccination in Europe: schedule adherenceAlain Gervaix, Filippo Ansaldi, António Brito-Avô, et al.
Pageof 12